Drugs / LPV400mg/RTV100mgBID
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00144105 | Feb 2004 → Nov 2006 | HIV infectious disease | Boehringer Ingelheim | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LPV400mg/RTV100mgBID | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00144105 ↗ |
| Known as | LPV | “400 mg Lopinavir (LPV) Plus 100 mg RTV p.o. BID” NCT00144105 ↗ |